Adverum Biotechnologies to Present at Upcoming Investor Conferences

Monday, February 26, 2018 2:01 PM UTC

MENLO PARK, Calif., Feb. 26, 2018 -- Adverum Biotechnologies, Inc. (Nasdaq:ADVM), a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases, announced today that Amber Salzman, Ph.D., president and chief executive officer of Adverum, will present at upcoming investor conferences in March.


Event:					Raymond James 39^th Annual Institutional Investors Conference
Date:					March 5, 2018
Time:					9:15 – 9:45 a.m. ET
Location:					Orlando, FL

Event:					Cowen and Company 38^th Annual Health Care Conference
Date:					March 12, 2018
Time:					1:30 – 2:00 p.m. ET
Location:					Boston, MA

A live and replay audio webcast of these presentations will be available from Adverum’s website at http://investors.adverum.com.

About Adverum Biotechnologies, Inc.
Adverum is a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases. Adverum has a robust pipeline that includes product candidates designed to treat rare diseases alpha-1 antitrypsin (A1AT) deficiency and hereditary angioedema (HAE) as well as wet age-related macular degeneration (wAMD). Leveraging a next-generation adeno-associated virus (AAV)-based directed evolution platform, Adverum generates product candidates designed to provide durable efficacy by inducing sustained expression of a therapeutic protein. Adverum has collaboration agreements with Regeneron Pharmaceuticals to research, develop, and commercialize gene therapy products for ophthalmic diseases and Editas Medicine to explore the delivery of genome editing medicines for the treatment of inherited retinal diseases. Adverum’s core capabilities include clinical development and in-house manufacturing expertise, specifically in process development and assay development. For more information please visit www.adverum.com.

Adverum Contact:
Leone Patterson
Chief Financial Officer
650-665-7222
[email protected]

Editor's Picks

Breathing through your nose when you exercise may make your runs easier

Entrepreneurs are facing a mental health crisis — here's how to help them

Are fish oil supplements as healthy as we think? And is eating fish better?

Will AI kill our creativity? It could – if we don’t start to value and protect the traits that make us human

Does AI have a right to free speech? Only if it supports our right to free thought

How can I lower my cholesterol? Do supplements work? How about psyllium or probiotics?

Why we need to set limits on sperm donation

Aging with a healthy brain: How lifestyle changes could help prevent up to 40% of dementia cases

Seven techniques to avoid weight regain, approved by experts

Adverum Biotechnologies to Present at Upcoming Investor Conferences

Editor's Picks

Welcome to EconoTimes